Beta-blocker therapy for tremor in Parkinson's disease

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2003, Pages

  Crosby, Niall J ^a   Deane, Katherine ^b   Clarke, Carl E ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREMOR;

ADRENERGIC BETA-ANTAGONISTS; ANTIPARKINSON AGENTS; CHEMOTHERAPY, ADJUVANT; HUMANS; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS; TREMOR;

EID: 18344399583     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003361     Document Type: Review

References (28)

1. Claveria LE, Vakil SD, George CF, Reid JL, Calne DB, Petrie A. Oxprenolol in Parkinsonism. The Journal of Clinical Pharmacology 1975;15(1):66-68.
2. Corbett JL. Efficacy of Oxprenolol in the Treatment of Essential and Parkinsonian Tremor - a Description of Two Controlled Trials and a Review of the Literature. In: Kielkholz P editor(s). Beta Blockers And The Central Nervous System. An International Symposium. Bern: Huber, 1976:200-217.
3. Henderson JM, Yiannikas C, Morris JG, Einstein R, Jackson D, Byth K. Postural tremor of Parkinson's disease. Clinical Neuropharmacology 1994;17(3):277-285.
4. Marsden CD, Parkes JD, Rees JE. Propranolol in Parkinson's disease. Lancet 1974;2(7877):410.
5. Abramsky O, Carmon A, Savy S. Combined treatment of parkinsonian tremor with propranolol and levodopa. Journal of Neurological Science 1971;14:491.
6. Chaturvedi SK. Metoprolol in the treatment of neuroleptic-induced tremor: case report. The Journal of Clinical Psychiatry 1987;48(9):378.
7. Dowzenko A, Buksowicz C, Kuran W. Effect of Coretal Polfa (Oxprenolol) on parkinsonian tremor and benign essential tremor. Neurol Neurochir Pol 1976;10(1):49-53.
8. Floru L. Clinical treatment of lithium induced tremors with a beta receptor antagonist (propranolol). Int Pharmacopsychiatry 1971;6(4):197-222.
9. Garcia-Talavera FB, Diaz MR, de Paz yAP. Atenolol in the control of parkinsonian tremor [Atenolol en el control del trmblor parkinsoniano]. Medicinia Clinica 1985;84(2):78-79.
10. Gilligan BS, Veale JL, Wodak J. Propranolol in the treatment of tremor. Medical Journal of Australia 1972;59(I):1455 (corresp).
11. Henderson JM, Einstein R, Jackson DM, Byth K, Morris JG. 'Atypical' tremor. European Neurology 1995;35:321-326.
12. Jackson R, Crawford CO, Peel JS. Oxprenolol in Parkinson's disease. New Zealand Medical Journal 1971;74:246.
13. Kissel P, Tridon P, Andre JM. [Levodopa-propranolol therapy in parkinsonian tremor]. The Lancet 1974:403-404.
14. Koller WC, Herbster G. Adjuvant therapy of Parkinsonian tremor. Archives of Neurology 1987;44:921-923.
15. Metzer WS, Paige SR, Newton JE. Inefficacy of propranolol in attenuation of drug-induced parkinsonian tremor. Movement Disorders 1993;8(1):43-46.
16. Owen DA, Marsden CD. Effect of adrenergic beta-blockade on parkinsonian tremor. Lancet 1965;2(7425):1259-1262.
17. Sandler M, Fellows LE, Calne DB, Findley LJ. Oxprenolol and levodopa in parkinsonian patients. Lancet 1975;I:168 (corresp).
18. Strang RR. Clinical trial with a beta-receptor antagonist (propanolol) in Parkinsonism. Journal of Neurology, Neurosurgey and Psychiatry 1965;28:404-406.
19. Takahashi A, Indo T. Clinical application in tremor due to essential tremor and Parkinson's disease - Focus on Inderal treatment. Diagnosis and Treatment 1988;76(12):3007-3012.
20. Vas C J. Propanolol in parkinsonian tremor. The Lancet 1966:182-183.
21. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. The Lancet 2001;357:1191-1194.
22. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 1988;51:745-752.
23. Gleiter CH, Deckert J. Adverse CNS-effects of beat-andrenoceptor blockers. Pharmacopsychiatry 1996;29(6):201-211.
24. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17(5):427-442.
25. Jankovic J, Fahn S. Physiologic and pathologic tremors. Annals of Internal Medicine 1980;93(3):460-465.
26. Koller WC. Diagnosis and treatment of tremors. Neurologic Clinics 1984;2(3):499-514.
27. Rajput AH, Rozdilsky B, Ang L. Occurence of resting tremor in Parkinson's disease. Neurology 1991;41(8):1298-1299.
28. Uitti RJ. Medical treatment of Essential Tremor and Parkinson's disease. Geriatrics 1998;53(5):46-8, 53-7.